Cam Gallagher - May 31, 2024 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
President, Interim CFO, Director
Signature
/s/ Andrea Paul, attorney-in-fact for Cam S. Gallagher
Stock symbol
ZNTL
Transactions as of
May 31, 2024
Transactions value $
-$114,972
Form type
4
Date filed
5/31/2024, 06:27 PM
Previous filing
Feb 12, 2024
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale -$115K -9.6K -1.49% $11.98 634K May 31, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Remarks:

Exhibit 24 - Power of Attorney